Expanding the therapeutic landscape: ezetimibe as non-statin therapy for dyslipidemia
Jeongmin Lee, Seung-Hwan Lee
Korean J Intern Med. 2023;38(6):797-809.   Published online 2023 Oct 20     DOI: https://doi.org/10.3904/kjim.2023.243
Citations to this article as recorded by Crossref logo
Recent Advances in the Management of Dyslipidemia: A Systematic Review
Huang Jacky Xiao Feng, Yousaf Adil, Moon Julie, Ahmed Ramiz, Uppal Krishma, Sudhakar Pemminati
Cureus.2025;[Epub]     CrossRef
Assessing Omega-3 Therapy and Its Cardiovascular Benefits: What About Icosapent Ethyl? A Systematic Review and Meta-Analysis
Nathália Mendes Machado, Maria Vitória Barroso Oliveira, Karina Quesada, Jesselina Francisco dos Santos Haber, Ricardo José Tofano, Claudio José Rubira, Tereza Lais Menegucci Zutin, Rosa Direito, Eliana de Souza Bastos Mazuqueli Pereira, Camila Marcondes
Pharmaceuticals.2025; 18(4): 601.     CrossRef
The structures and regulatory roles of natural products in lipid metabolism: focus on medicinal and edible plants
Xinjian Zhang, Sheng Li, Bodou Zhang, Yu Zhang
Food Science and Human Wellness.2025; 14(5): 9250365.     CrossRef
Impact of early initiation of ezetimibe in patients with acute coronary syndrome: A systematic review and meta-analysis
Kunal Mahajan, Lakshmi Nagendra, Anil Dhall, Deep Dutta
European Journal of Internal Medicine.2024; 124: 99.     CrossRef
The Pleiotropic Effects of Lipid-Modifying Interventions: Exploring Traditional and Emerging Hypolipidemic Therapies
Dimitris Kounatidis, Nikolaos Tentolouris, Natalia G. Vallianou, Iordanis Mourouzis, Irene Karampela, Theodora Stratigou, Eleni Rebelos, Marina Kouveletsou, Vasileios Stamatopoulos, Eleni Tsaroucha, Maria Dalamaga
Metabolites.2024; 14(7): 388.     CrossRef
The functions of apolipoproteins and lipoproteins in health and disease
Zijun Ma, Jixin Zhong, Wei Tu, Shiliang Li, Jun Chen
Molecular Biomedicine.2024;[Epub]     CrossRef
Efficacy and safety of moderate-intensity rosuvastatin plus ezetimibe versus high-intensity rosuvastatin monotherapy in the treatment of composite cardiovascular events with hypercholesterolemia: A meta-analysis
Lingyan Liu, Yongkun Deng, Lei Li, Xingbiao Yang, Zhaoheng Yin, Yong Lai, Jaspinder Kaur
PLOS ONE.2024; 19(11): e0310696.     CrossRef
Advancements in the Treatment of Atherosclerosis: From Conventional Therapies to Cutting-Edge Innovations
Yan Liu, Kuan Lu, Ruru Zhang, Dongliang Hu, Zhe Yang, Jianfeng Zeng, Wu Cai
ACS Pharmacology & Translational Science.2024; 7(12): 3804.     CrossRef